Quick Answer
BioCardia, Inc. reported Cash And Cash Equivalents At Carrying Value of $2.50 million for the year ending 2025.
- BioCardia, Inc. showed an increase of +5.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from BioCardia, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $1.67 million | Q1 2011: $241.0 thousand | Q2 2011: $12.69 million | Q3 2011: $12.61 million | Q1 2012: $12.65 million | Q2 2012: $12.88 million | Q1 2013: $13.25 million | Q2 2013: $13.27 million | Q3 2013: $13.26 million | Q4 2013: $13.30 million | Q1 2014: $13.32 million | Q2 2014: $13.40 million | Q3 2014: $13.46 million | Q1 2015: $13.60 million | Q2 2015: $13.69 million | Q3 2015: $13.73 million | Q1 2016: $2.81 million | Q2 2016: $1.69 million | Q3 2016: $552.0 thousand | Q4 2016: $24.00 million | Q1 2017: $19.03 million | Q2 2017: $15.11 million | Q3 2017: $13.33 million | Q1 2018: $9.65 million | Q2 2018: $6.83 million | Q3 2018: $4.82 million | Q4 2018: $5.36 million | Q1 2019: $2.84 million | Q2 2019: $517.0 thousand | Q3 2019: $8.91 million | Q1 2020: $2.59 million | Q2 2020: $11.09 million | Q3 2020: $7.39 million | Q1 2021: $21.50 million | Q2 2021: $18.54 million | Q3 2021: $15.89 million | Q1 2022: $6.70 million | Q2 2022: $8.61 million | Q3 2022: $6.67 million | Q1 2023: $4.86 million | Q2 2023: $4.31 million | Q3 2023: $1.84 million | Q1 2024: $949.0 thousand | Q2 2024: $1.42 million | Q3 2024: $4.93 million | Q1 2025: $949.0 thousand | Q2 2025: $980.0 thousand | Q3 2025: $5.29 million.
- Over the full 19 years of available data (2009 to 2025), BioCardia, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 49.8%.
- Historical annual values: Fiscal year 2025: $2.50 million | Fiscal year 2024: $2.37 million | Fiscal year 2023: $1.10 million | Fiscal year 2022: $7.36 million | Fiscal year 2021: $12.87 million | Fiscal year 2020: $21.41 million | Fiscal year 2019: $5.59 million | Fiscal year 2018: $5.36 million | Fiscal year 2017: $12.69 million | Fiscal year 2016: $21.35 million | Fiscal year 2016: $24.00 million | Fiscal year 2015: $3.56 million | Fiscal year 2014: $3.18 million | Fiscal year 2013: $13.30 million | Fiscal year 2012: $13.27 million | Fiscal year 2012: $12.82 million | Fiscal year 2011: $12.68 million | Fiscal year 2010: $127.0 thousand | Fiscal year 2009: $4.97 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: